Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.2B | 1.5B | 1.4B | 1.3B |
Cost of revenue | 551M | 558M | 563M | 552M |
Gross profit | 683M | 929M | 803M | 717M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 257M | 270M | 278M | 269M |
Other operating expenses | 1M | — | — | — |
Operating income | 220M | 441M | 335M | 240M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 97M | 104M | 113M | 113M |
Other income expense | 15M | 0 | 22M | 22M |
Pretax income | 138M | 337M | 244M | 149M |
Tax provision | 41M | 107M | 64M | 43M |
Net income | 97M | 230M | 180M | 106M |
Basic EPS | 3.4 | 7.7 | 5.3 | 3.6 |
Diluted EPS | 3.4 | 7.6 | 5.3 | 3.5 |
Basic average shares | 30.5M | 31.0M | 32.0M | 32.8M |
Diluted average shares | 30.9M | 31.4M | 32.4M | 33.3M |
EBITDA | 440M | 685M | 547M | 470M |
Net income from continuing op. | 97M | 230M | 180M | 106M |
Minority interests | 11M | 12M | 7M | 12M |
Preferred stock dividends | — | — | — | — |